Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NSCLC Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07392658
What this trial is testing

Phase II Trial of Amivantamab Plus Monochemotherapy in Platinum Unfit NSCLC Patients With EGFR exon20 Insertion Mutations.

Who this might be right for
Metastatic NSCLC - Non-Small Cell Lung Cancer
Fondazione Ricerca Traslazionale 33
Testing effectiveness (Phase 2)Ended earlyNCT00417248
What this trial is testing

Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Nasser Hanna, M.D. 8
Not applicableStudy completedNCT00900835
What this trial is testing

Pain and Fatigue Management in Patients With Breast Cancer, Prostate Cancer, Colon Cancer, or Lung Cancer

Who this might be right for
Breast CancerColorectal CancerFatigue+3 more
City of Hope Medical Center 470
Testing effectiveness (Phase 2)Ended earlyNCT06171789
What this trial is testing

PRO1107 in Patients With Advanced Solid Tumors

Who this might be right for
Endometrial CancerOvarian CancerTriple Negative Breast Cancer+3 more
Genmab 33
Early research (Phase 1)Study completedNCT01005797
What this trial is testing

Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers

Who this might be right for
Renal CancerNon Small Cell Lung Cancer (NSCLC)Soft Tissue Sarcoma
Medical University of South Carolina 38
Testing effectiveness (Phase 2)Study completedNCT00615758
What this trial is testing

Erlotinib as 1st Line Treatment in NSCLC Stage IIIB/IV

Who this might be right for
Non Small Cell Lung Cancer
Hellenic Oncology Research Group 50
Not applicableEnded earlyNCT02067858
What this trial is testing

An Outcome Analysis for Stereotactic Body Radiation Therapy (SBRT) Treatment of Non-Small Lung Cancer Patients Using 4D PET/CT With Real-Time Position Management (RPM™) System and a Concomitant Evaluation of the Impact and Performance Characteristics of the Immobilization System

Who this might be right for
Non Small Cell Lung Cancer4D CT
Steven Burton 6
Very early researchEnded earlyNCT03454243
What this trial is testing

Oral Immunomodulatory Tyrosine Kinase Inhibitor in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Hoffmann-La Roche 1
Not applicableStudy completedNCT01729689
What this trial is testing

Cognitive Behavioral Therapy in Treating Anxiety in Patients With Stage IV Non-Small Cell Lung Cancer and Their Caregivers

Who this might be right for
Anxiety DisorderRecurrent Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
Stanford University 13
Large-scale testing (Phase 3)Study completedNCT00002623
What this trial is testing

Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 640
Not applicableStudy completedNCT05380908
What this trial is testing

Brain Metabolic Network of PET in Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Advanced Non-small-cell Lung Cancer
Fifth Affiliated Hospital, Sun Yat-Sen University 90
Testing effectiveness (Phase 2)Study completedNCT00190840
What this trial is testing

A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell Lung
Eli Lilly and Company 186
Testing effectiveness (Phase 2)UnknownNCT02069418
What this trial is testing

Theranostic Tool During Erlotinib Treatment in Non-small Cell Lung Cancer Patient

Who this might be right for
Non-small Cell Lung Cancer Metastatic or Non-small Cell Lung Cancer RecurrentNo EGFR Activating Mutation
University Hospital, Angers 80
Large-scale testing (Phase 3)Study completedNCT00440414
What this trial is testing

Trial of Pemetrexed Versus Erlotinib in Pretreated Patients With Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Hellenic Oncology Research Group 320
Not applicableStudy completedNCT00641238
What this trial is testing

Outcome of Patients With Lung Masses Who Are Treated With Radiofrequency Ablation (RFA)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
State University of New York - Upstate Medical University 20
Not applicableStudy completedNCT00089310
What this trial is testing

Sentinel Lymph Node Mapping in Detecting Cancer That Has Spread to Lymph Nodes in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 46
Testing effectiveness (Phase 2)Study completedNCT00630110
What this trial is testing

Phase 1/2 Study of Vascular Disrupting Agent NPI-2358 + Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Cancer
Nereus Pharmaceuticals, Inc. 172
Testing effectiveness (Phase 2)Ended earlyNCT00601848
What this trial is testing

Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the Pleura

Who this might be right for
Lung CancerMetastatic Cancer
Abramson Cancer Center at Penn Medicine 9
Not applicableStudy completedNCT01182155
What this trial is testing

Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation

Who this might be right for
Lung CancerNon-Small Cell Lung CancerSmall Cell Lung Cancer
Stanford University 20
Early research (Phase 1)Study completedNCT00028535
What this trial is testing

Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors

Who this might be right for
Male Breast CancerRecurrent Breast CancerRecurrent Endometrial Carcinoma+4 more
National Cancer Institute (NCI) 18
Next Page